IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. More...

Descripción completa

Detalles Bibliográficos
Autores principales: Borovcanin, Milica M., Janicijevic, Slavica M., Jovanovic, Ivan P., Gajovic, Nevena, Arsenijevic, Nebojsa N., Lukic, Miodrag L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024021/
https://www.ncbi.nlm.nih.gov/pubmed/29988422
http://dx.doi.org/10.3389/fpsyt.2018.00271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024021/
https://www.ncbi.nlm.nih.gov/pubmed/29988422
http://dx.doi.org/10.3389/fpsyt.2018.00271

Ejemplares similares